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A ROLE FOR CHEMOKINES AND NGF IN PAIN GENERATION IN A
MURINE MODEL OF OSTEOARTHRITIS
R.E. Miller, P. Tran, N. Ghoreishi-Haack, R. Das, A-M. Malfait. Rush Univ.
Med. Ctr., Chicago, IL, USA
Purpose: Pain is the major symptom in osteoarthritis (OA), yet how
this pain develops remains unknown. We recently reported that
destabilization of the medial meniscus (DMM) provides a suitable mouse
model for studying pain development and progression at different stages
of OA. We found that, following DMM in the right knee, male C57BL/6
mice develop progressive mechanical allodynia in the ipsilateral hindpaw,
as early as 2 weeks and progressing over 8 weeks post DMM (but
not sham) surgery. Additionally, total distance traveled over a speciﬁed
period was relatively constant over the ﬁrst 8 weeks, but decreased from
12 to 16 weeks after surgery. The current goal was to identify molecular
pathways in the knee joint and its innervating nociceptive system that
correlate with these different stages of disease.
Methods: DMM or sham surgery was performed in the right knee
of 10-week old male C57BL/6 mice. At 8 and 16 weeks post
surgery, histopathology of the knees was evaluated according to OARSI
recommendations. Additionally, at 4 and 8 weeks after surgery, whole
knee joints were collected for protein extraction and ELISA. At 4, 8,
or 16 weeks post surgery, innervating dorsal root ganglia (DRG), L3-
L5, from DMM or sham-operated mice and age-matched naïve mice
were collected for protein extraction for ELISA or for mRNA extraction
for quantitative RT-PCR of nerve growth factor (NGF), monocyte
chemoattractant protein (MCP)-1 and its receptor CCR2, and stromal
cell-derived factor (SDF)-1. Finally, at 8 weeks post surgery, the response
of DRG neurons to chemokines was recorded though intracellular Ca2+-
imaging, following standard protocols. In brief, DRG neurons were acutely
isolated, plated on coverslips, cultured for 3–4 days, and loaded with a
calcium indicator dye. The number of cells responding to chemokines
was counted.
Results: Following DMM (but not sham) surgery, C57BL/6 mice developed
cartilage degeneration and osteophyte formation by 8 weeks in the
ipsilateral knee only, with progressive cartilage deterioration occurring
up to 16 weeks. At 4 weeks post DMM, protein levels of MCP-1 and NGF
were elevated in total joint extracts from the operated knee compared
to naïve age-matched controls (p = 0.025 and p=0.099, respectively); by
8 weeks post DMM, levels of both proteins had returned to baseline.
mRNA levels of NGF, MCP-1, CCR2, and SDF-1 in the innervating DRGwere
upregulated compared to naïve and sham age-matched controls, peaking
at 8 weeks post surgery. Protein levels of NGF were also increased in
DRG at 8 weeks post surgery (p = 0.03), while MCP-1 protein was below
the detection limit at all time points.
Exposing isolated DRG neurons from DMM mice at 8 weeks post surgery
to MCP-1 or to SDF-1 (200 or 500ng/mL, respectively) resulted in an
increased intracellular calcium response compared to naïve age-matched
controls, indicating an upregulation of their respective receptors, CCR2
and CXCR4, on these cells.
Conclusions: In this study, gene and protein expression in the knee joint
and innervating DRG of DMM mice reveal temporal changes in NGF,
SDF-1 and MCP-1 during the development of painful OA. In addition,
Ca-imaging studies suggest a functional role for the chemokines MCP-1
and SDF-1 in pain generation in this model. NGF is known to play a
role in sensitization of the nervous system in inﬂammation-associated
pain; recent research has shown that the chemokines MCP-1 and SDF-1
contribute to the development of chronic pain in neuropathic pain
models. Therefore, this work supports burgeoning clinical evidence
that OA-related pain may include aspects of both inﬂammatory and
neuropathic pain.
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QUADRICEPS WEAKNESS PREDICTS WORSENING OF KNEE PAIN
AND FUNCTION IN THE MOST COHORT: A LONGITUDINAL STUDY
N. Segal1, N.A. Glass1, J. Torner1, K. Wang2, D.T. Felson2, M. Nevitt3,
C.E. Lewis4. 1Univ. of Iowa, Iowa City, IA, USA; 2Boston Univ., Boston, MA,
USA; 3Univ. of California at San Francisco, San Francisco, CA, USA; 4Univ. of
Alabama at Birmingham, Birmingham, AL, USA
Purpose: To inform interventions to maximize physical function in older
adults at elevated risk for knee osteoarthritis (OA) or who have knee OA,
through determining whether quadriceps weakness is associated with
an elevated odds of worsening of knee pain and functional limitations.
Methods: The MOST Study is a longitudinal study of 50–79 year old men
and women with knee OA or known risk factors for knee OA (e.g. BMI
greater than or equal to 25 kg/m2, or history of knee pain, surgery or
injury).
Baseline measures included isokinetic concentric quadriceps strength,
height and weight, physical activity, and the WOMAC questionnaire.
Worsening of pain and physical function between baseline and 30-
month follow-up was deﬁned as the minimum detectable change at
the 90% conﬁdence level (MDC90) using a modiﬁcation of the formula
utilized by Wyrwich to estimate of the minimum change in subscale
score which would denote an important difference. This was selected
for evaluating meaningful changes in WOMAC scores because small
differences in mean scores might be statistically signiﬁcant simply due
to large sample sizes that may not necessarily translate to meaningful
change. Pain analyses were knee-based and controlled for covariance
between knees while physical function analyses were person-based.
Analyses used generalized estimating equations (GEE) stratiﬁed by sex
to assess relationships between baseline strength and worsening of knee
pain or function, controlling for age, BMI, history of knee injury and/or
surgery, and Physical Activity Scale for the Elderly score.
Results: Analyses of worsening knee pain included 4525 knees,
while analyses of worsening function included 2175 participants
(59.8% women). Neither men nor women with low compared with high
strength were at increased risk for worsening pain or worsening physical
function 30 months later (see tables).
The association between baseline quadriceps strength and worsening of
WOMAC pain score








Men 570 (5.8) High (Referent)
570 (5.8) Middle 0.99 (0.61–1.62) 0.9690
560 (8.2) Low 1.37 (0.82–2.28) 0.2332
Women 907 (6.2) High (Referent)
906 (8.2) Middle 1.29 (0.88–1.89) 0.1887
892 (8.1) Low 1.12 (0.74–1.70) 0.5768
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The association between baseline quadriceps strength and worsening of
WOMAC function score








Men 274 (6.5) High (Referent)
277 (5.5) Middle 0.69 (0.32, 1.46) 0.3145
277 (6.1) Low 0.68 (0.34, 1.42) 0.3241
Women 437 (4.4) High (Referent)
432 (4.2) Middle 0.97 (0.49, 1.92) 0.9308
425 (6.4) Low 1.58 (0.82, 3.03) 0.1685
Conclusions: Quadriceps weakness was not associated with an increased
risk for worsening of knee pain severity or worsening self-reported
physical function over 30 months in either men or women. For the goals
of minimizing risk for impairments and functional limitations, these
data do not appear to support the importance of maintaining adequate
quadriceps strength in men and women with or at increased risk for
knee OA.
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SERUM OPIOID MONITORING IN OSTEOARTHRITIS PATIENTS WITH
CHRONIC PAIN: THE SEARCH FOR SENSITIVE BIOMARKERS
Y. Savitskaya, C. Duarte, N. Marin, R. Tellez, A. Alfaro, A. Izaguirre,
E. Villalobos, A. Almazan, C. Ibarra. Natl. Inst. of Rehabilitation, Mexico,
Mexico
Background: Osteoarthritis (OA), a common, minimally inﬂammatory
rheumatological syndrome characterized by chronic joint pain and
dysfunction, the primary symptom of OA is pain that is seen as entirely
linked with function, with physical movements triggering pain, while
pain, in turn, causes limitations in physical function. Chronic pain has
been associated with augmented circulating catecholamines (CAs) and
bradykinin. The presence of natural antibodies (NA) regarding speciﬁcity
and have gained increasing attention in proteome analysis for developing,
monitoring and effective treatment of OA.
Objectives: The objective of the study was to test of natural antibodies
against serum proteins relevant to pain (dopamine DA, adrenaline AD,
noradrenaline NA, bradykinin BK) expression on chronic osteoarthritis
pain.
Methods: We evaluated 75 individuals with chronic pain (>3 months)
due to OA. Pain was moderate to severe (>4 of 10), as self-assessed with
Likert scale (0 to 10) using a daily pain diary for 2 wk before outpatient
screening assessment. The clinical diagnosis of OA was further conﬁrmed
using Kellgren and Lawrence radiographic scoring criteria. 75 healthy
individuals without OA or other pain syndromes, of similar age and
body mass index (BMI), were evaluated as control subjects Table 1. We
compared circulating concentrations of NA against CAs, BK in the using
express ELISA protocol (INR).
Results: We detected signiﬁcantly higher concentrations of DA-IgG and
BK-IgG in OA patients compared with healthy control. In addition, we
found signiﬁcant relationships between serum DA-IgG and BK-IgG in
patients with chronic, moderate to severe OA pain. Elevated DA-IgG
was signiﬁcantly correlated with BK-IgG (r = 0.91; P < 0.005) and VAS
(r = 0.75; P < 0.001) in OA patients. There were no statistically signiﬁcant
differences in mea values for NA to AD and NA in OA patients, compared
with healthy control subjects.
Conclusions: Evaluated together DA-IgG and BK-IgG, they can give
important information about immune system functioning, especially
relating to pain and vascular homeostasis. High throughput technology
has made major contributions to the study autoantigen-antibody systems
as serological markers of pain in OA. Quick and easy to perform ELISA test
for detect DA-IgG/BK-IgG can be routinely used in clinical laboratories.
Our results have potential applications for controlling unwanted pain
and future response to therapy in OA patients.
Table 1. Baseline characteristics
Age (yr) 54±8.8 51±11.1
BMI (kg/m2) 26±2.5 26±3.3
Duration of OA (yr) 13.0±9.8
Pain (visual analog) scores 5.46±2.15 0.00±0.00
Beck Depression Index 5.56±5.69 1.00±1.86
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OSTEOPONTIN LEVEL IN SYNOVIAL FLUID IS ASSOCIATED WITH THE
SEVERITY OF KNEE JOINT PAIN
M. Yamaga, K. Tsuji, K. Miyatake, J. Yamada, I. Sekiya, T. Muneta. Tokyo
Med. and Dental Univ., Tokyo, Japan
Purpose: Osteopontin (OPN) is an O-glycosylated phosphoprotein which
is synthesized in a variety of tissues and cells including chondrocytes and
synoviocytes. Accumulating data indicated that OPN is involved in the
process of inﬂammation, immunity, and bone metabolism. OPN knockout
mice have already been created and shown that cartilage degradation
is accelerated in the absence of OPN. Human studies revealed that OPN
protein level increased in the synovial ﬂuid from the patients suffering
from OA and RA. These data strongly suggest that OPN is involved in joint
homeostasis and in the pathogenesis of arthritis. However, the molecular
functions of OPN in these processes are not yet extensively studied. Here
we report that synovial ﬂuid OPN level is associated with the severity of
joint pain.
Methods: This study was approved by the Ethics Committee of
this institute. All patients included in this study gave their full,
written, informed consent for participation prior to the operative
procedure. Tissue samples (synovial ﬂuid and synovial membrane)
were obtained from the patients who underwent anterior cruciate
ligament reconstruction (ACL-R) or total knee arthroplasty (TKA) from
January 2009 till October 2010 in our hospital (OA: 27 samples,
female: 22 male: 5, range 51–90 year-old, average 77 year-old, ACL-R: 17
samples, female: 4 male: 13, range 18–47 year-old, average 27 year-old).
OPN mRNA expressed in synovial membrane was quantiﬁed by RT-QPCR
(Roche, Light Cycler 480, Germany). Total OPN protein levels in synovial
ﬂuid were quantiﬁed using OPN/OPN N-half ELISA kit (IBL, Japan) and
compared them with clinical parameters such as Lysholm score (ACL-R),
visual analogue scale (VAS, TKA), serum C-reactive protein (CRP) level,
and macroscopic observation of cartilage degradation.
Results and Discussion: As previously reported, OPN mRNA expression
level in synovial membrane and OPN protein level in synovial ﬂuid were
signiﬁcantly increased in OA if compared with those of ACL-R.
In the ACL-R group, OPN protein level in synovial ﬂuid was gradually
decreased after the injury. We found that OPN protein level in
synovial ﬂuid was POSITIVELY associated with the severity of joint
pain (Lysholm Score) although it was not statistically signiﬁcant. Since
OPN acts as a pro-inﬂammatory cytokines by enhancing migration,
survival, phagocytosis, and pro-inﬂammatory cytokine production of
macrophages, we hypothesized that OPN induces joint pain by promoting
inﬂammation in the joint. To test this hypothesis, we investigated the
correlation of OPN protein level in synovial ﬂuid with serum CRP level.
However, we did not observe any correlation between these two. Further
analysis is required to elucidate if our hypothesis is correct or not.
Since accelerated degradation of articular cartilage is observed in OPN
knockout mice, we next investigated the correlation of OPN protein
level in synovial ﬂuid with the macroscopic observation of cartilage
degradation. However, we also did not observe any correlation between
these two parameters.
In the TKA group, most interestingly, OPN protein level in synovial ﬂuid
was NEGATIVELY correlated with the severity of joint pain (VAS) in
OA patients (R = −0.469) but not with the serum CRP level by Pearson
product-moment correlation coefﬁcient analysis. These data represent
stark contrast to those of ACL-R group, and further analyses is required
to elucidate the roles of OPN in the regulation of knee joint pain.
Conclusions: Osteopontin level in synovial ﬂuid was associated with the
severity of joint pain. In the ACL-R group, it is POSITIVELY associated
with the severity of joint pain, however, NEGATIVELY correlated in the
TKA group.
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IDENTIFYING PAIN VULNERABILITY PHENOTYPES IN
OSTEOARTHRITIS
A.E. Nelson1, R.F. DeVellis1,2, B.M. DeVellis2, Y.M. Golightly1,
W. Maixner3,4, J.M. Jordan1. 1Univ. of North Carolina, Thurston Arthritis
Res. Ctr., Chapel Hill, NC, USA; 2Univ. of North Carolina, Gillings Sch. of
Global Publ. Hlth., Dept. of Hlth.Behavior and Hlth.Ed., Chapel Hill, NC, USA;
3Univ. of North Carolina, Sch. of Med., Dept of Endodontics, Chapel Hill, NC,
USA; 4Univ. of North Carolina, Dept. of Pharmacy, Chapel Hill, NC, USA
Purpose: Joint symptoms do not correlate perfectly with structural
damage in osteoarthritis (OA), and it is known that psychosocial issues,
